Analysis of adult 20-year survivors after liver transplantation

被引:30
|
作者
Dopazo, C. [1 ]
Bilbao, I. [1 ]
Castells, L. L. [2 ]
Sapisochin, G. [1 ]
Moreiras, C. [1 ]
Campos-Varela, I. [2 ]
Echeverri, J. [1 ]
Caralt, M. [1 ]
Lazaro, J. L. [1 ]
Charco, R. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept HBP Surg & Transplants, Barcelona 08035, Spain
[2] Univ Autonoma Barcelona, CIBERehd, Hosp Vall dHebron, Hepatol Unit,Dept Internal Med, Barcelona 08035, Spain
关键词
Liver transplantation; Long-term outcome; Immunosuppression; Risk factors; TERM MEDICAL COMPLICATIONS; ONSET DIABETES-MELLITUS; QUALITY-OF-LIFE; MYCOPHENOLATE-MOFETIL; TACROLIMUS MONOTHERAPY; ALLOGRAFT-REJECTION; PREDICTIVE FACTORS; RENAL-FUNCTION; RISK-FACTORS; FOLLOW-UP;
D O I
10.1007/s12072-014-9577-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation (LT) is the treatment of choice for chronic and acute liver failure; however, the status of long-term survivors and allograft function is not well known. To evaluate the clinical outcome and allograft function of survivors 20 years post-LT, cause of death during the same period and risk factors of mortality. A retrospective study was conducted from prospective, longitudinal data collected at a single center of adult LT recipients surviving 20 years. A comparative sub-analysis was made with patients who were not alive 20 years post-transplantation to identify the causes of death and risk factors of mortality. Between 1988 and 1994, 132 patients received 151 deceased-donors LT and 28 (21 %) survived more than 20 years. Regarding liver function in this group, medians of AST, ALT and total bilirubin at 20 years post-LT were 33 IU/L (13-135 IU/L), 27 (11-152 IU/L) and 0.6 mg/dL (0.3-1.1 mg/dL). Renal dysfunction was observed in 40 % of patients and median eGFR among 20-year survivors was 64 mL/min/1.73 m(2) (6-144 mL/min/1.73 m(2)). Sixty-one percent of 20-year survivors had arterial hypertension, 43 % dyslipidemia, 25 % de novo tumors and 21 % diabetes mellitus. Infections were the main cause of death during the 1st year post-transplant (32 %) and between the 1st and 5th year post-transplant (25 %). After 5th year from transplant, hepatitis C recurrence (22 %) became the first cause of death. Factors having an impact on long-term patient survival were HCC indication (p = 0.049), pre-transplant renal dysfunction (p = 0.043) and long warm ischemia time (p = 0.016); furthermore, post-transplant factors were diabetes mellitus (p = 0.001) and liver dysfunction (p = 0.05) at 1 year. Our results showed the effect of immunosuppression used during decades on long-term outcome in our LT patients in terms of morbidity (arterial hypertension, diabetes mellitus, dyslipidemia and renal dysfunction) and mortality (infections and hepatitis C recurrence).
引用
收藏
页码:461 / 470
页数:10
相关论文
共 50 条
  • [1] Analysis of adult 20-year survivors after liver transplantation
    C. Dopazo
    I. Bilbao
    L. L. Castells
    G. Sapisochin
    C. Moreiras
    I. Campos-Varela
    J. Echeverri
    M. Caralt
    J. L. Lázaro
    R. Charco
    Hepatology International, 2015, 9 : 461 - 470
  • [2] Analyses of 20-Year Survivors after Liver Transplantation in Adults
    Dopazo, Cristina
    Bilbao, Itxarone
    Castells, Lluis
    Sapisochin, Gonzalo
    Moreiras, Cristian
    Campos, Isabel
    Echeverri, Juan
    Caralt, Mireia
    Luis Lazaro, Jose
    Charco, Ramon
    LIVER TRANSPLANTATION, 2014, 20 : S264 - S265
  • [3] Long-Term Patient Outcome and Quality of Life After Liver Transplantation Analysis of 20-Year Survivors
    Duffy, John P.
    Kao, Kenneth
    Ko, Clifford Y.
    Farmer, Douglas G.
    McDiarmid, Sue V.
    Hong, Johnny C.
    Venick, Robert S.
    Feist, Susan
    Goldstein, Leonard
    Saab, Sammy
    Hiatt, Jonathan R.
    Busuttil, Ronald W.
    ANNALS OF SURGERY, 2010, 252 (04) : 652 - 659
  • [4] 20-Year Survivors of Heart Transplantation at Stanford University
    Deuse, T.
    Haddad, E.
    Pham, M.
    Hunt, S.
    Valantine, H.
    Oyer, P.
    Robbins, R. C.
    Reitz, B. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S166 - S166
  • [5] Long-term outcome of liver transplantation in childhood: Astudy of 20-year survivors
    Martinelli, J.
    Habes, D.
    Majed, L.
    Guettier, C.
    Gonzales, E.
    Linglart, A.
    Larue, C.
    Furlan, V.
    Pariente, D.
    Baujard, C.
    Branchereau, S.
    Gauthier, F.
    Jacquemin, E.
    Bernard, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (07) : 1680 - 1689
  • [6] Dual heart liver transplantation: a 20-year analysis in the United States
    Anouti, A.
    Dakroub, A.
    Krayem, H.
    VanWagner, L.
    Cotter, T.
    Lee, W.
    LIVER TRANSPLANTATION, 2024, 30 : 40 - 41
  • [7] Liver Transplantation for Polycystic Liver Disease: A 20-Year Experience
    Baber, J.
    Agopian, V.
    Hiatt, J.
    Busuttil, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 223 - 223
  • [8] Expanded Criteria for Hepatocellular Carcinoma after Liver Transplantation: A 20-Year Evolution
    Lai, Q.
    Nudo, F.
    Mennini, G.
    Spoletini, G.
    Morabito, V
    Sandri, Levi G. B.
    Melandro, F.
    Guglielmo, N.
    Berloco, P. B.
    Rossi, M.
    HEPATO-GASTROENTEROLOGY, 2013, 60 (128) : 2039 - 2041
  • [9] Ten- and 20-year survivors of pediatric orthotopic heart transplantation
    Ross, M
    Kouretas, P
    Gamberg, P
    Miller, J
    Burge, M
    Reitz, B
    Robbins, R
    Chin, C
    Bernstein, D
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (03): : 261 - 270
  • [10] Biliary complications after pediatric liver transplantation: experience over a 20-year period
    Samuel, Luethold
    Valerie, McLin A.
    Dominique, Belli C.
    Barbara, Wildhaber E.
    SWISS MEDICAL WEEKLY, 2011, 141 : 8S - 8S